AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Phathom Pharmaceuticals, Inc. Director's Dealing 2019

Oct 25, 2019

32407_dirs_2019-10-24_4a323675-4c29-425c-9102-70abb3552080.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2019-10-24

Reporting Person: Kohli Aditya (Chief Business Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	843352	Direct

Footnotes

F1: 540,272 shares are subject to a right of repurchase by Phathom Pharmecuticals, Inc.